Assessing the Effect of an Antioxidant-Rich Diet on Metabolic Syndrome Risk Using the Dietary Antioxidant Index
AD-MetS-DAI
1 other identifier
interventional
55
1 country
1
Brief Summary
Metabolic syndrome (MetS) is a cluster of metabolic disorders characterized by elevated levels of blood glucose, hypertension, dyslipidemia, and abdominal obesity. Globally, it is a major public health concern. International studies have linked higher Dietary Antioxidant Index with reduced risk of MetS, as antioxidants play a role in lowering the risk of MetS by reducing oxidative stress, a key contributor to its pathophysiology. Exploring this link in Pakistan can provide valuable insights for dietary strategies to reduce the risk of MetS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2026
CompletedJanuary 21, 2026
December 1, 2025
3 months
December 17, 2025
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Dietary Antioxidant Index (DAI)
DAI will be calculated from 24-hour dietary recalls to quantify total antioxidant intake. The primary objective is to assess whether the antioxidant-rich diet increases DAI in participants.
Baseline and after 12 weeks of intervention
Change in Metabolic Syndrome Risk Score
A composite metabolic syndrome risk score will be calculated by summing standardized z-scores of waist circumference (cm), fasting blood glucose (mg/dL), systolic blood pressure (mmHg), triglycerides (mg/dL), and inversely weighted HDL-cholesterol (mg/dL) to generate a single continuous measure of overall metabolic syndrome risk.
Baseline and after 12 weeks of intervention
Secondary Outcomes (1)
Change in Body Composition
Baseline and after 12 weeks of intervention
Study Arms (1)
Dietary Antioxidant Index-Based Dietary Intervention Arm
EXPERIMENTALParticipants in this arm will receive an antioxidant-rich dietary intervention designed to improve the Dietary Antioxidant Index (DAI). The intervention includes guidance to increase intake of fruits, vegetables, whole grains, legumes, and antioxidant-rich foods while limiting pro-oxidant and ultra-processed foods. Changes in DAI and metabolic syndrome components will be assessed before and after the intervention.
Interventions
This intervention specifically targets the Dietary Antioxidant Index (DAI) by increasing consumption of antioxidant-rich foods such as fruits, vegetables, whole grains, and legumes, while limiting pro-oxidant and ultra-processed foods. Unlike general healthy diet interventions, this study focuses on quantifiable antioxidant intake and its direct association with metabolic syndrome risk in urban adults.
Eligibility Criteria
You may qualify if:
- Adults aged 18-45 years
- Metabolic syndrome risk (abdominal obesity \& elevated BP as per NCEP ATP III criteria).
- Low fruit \& veg intake (\<5 serv./day) as per WHO.
- Willing to follow an intervention
- Non-pregnant or lactating
- Not diagnosed with malabsorption syndrome or chronic illness
You may not qualify if:
- Individuals \< 18 years or \> 45 years
- Not at risk of metabolic syndrome.
- Adequate intake of fruits \& veg (≥ 5 serv./day) as per WHO
- Not willing
- Pregnant or lactating
- Diagnosed with malabsorption syndrome or chronic illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Veterinary & Animal Sciences, Lahore Pakistan
Lahore, Punjab Province, 54000, Pakistan
Study Officials
- PRINCIPAL INVESTIGATOR
Qaisar Raza, Ph.D
UNIVERSITY OF VETERINARY & ANIMAL SCIENCES, LAHORE PAKISTAN.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 17, 2025
First Posted
January 21, 2026
Study Start
January 1, 2026
Primary Completion
April 1, 2026
Study Completion
April 15, 2026
Last Updated
January 21, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share